Market Research Logo

Asia-Pacific MICE industry by Event Type (Meetings, Incentives, Conventions, and Exhibitions), and Country (China, India, Singapore, Thailand, Indonesia, Australia, New Zealand, Japan, Malaysia, South Korea, Vietnam, Hong Kong, and rest of Asia-Pacific):

Asia-Pacific MICE industry by Event Type (Meetings, Incentives, Conventions, and Exhibitions), and Country (China, India, Singapore, Thailand, Indonesia, Australia, New Zealand, Japan, Malaysia, South Korea, Vietnam, Hong Kong, and rest of Asia-Pacific): Opportunity Analysis and Industry Forecast, 2018 - 2025

MICE Industry Market Overview:

Meetings, Incentives, Conventions and Exhibitions or MICE represents a sector of tourism that includes business events and activities. In general, MICE are events and activities that involve attendees who share a common interest and gather at a place. Travelers attending MICE activities are business travelers who are connected to different sectors of the tourism and hospitality industry through their MICE activities. The MICE service providers consist of a group of organizers and suppliers that provide wide range of services related to business events and activities such as kiosks/exhibit space, on-site event logistics and staffing, event marketing and sponsorship management, event photography and AV/technical production, displays, directional signage, banners, supplier management, virtual meetings, and risk management services.

The Asia-Pacific MICE industry generated revenue of $229.0 billion in 2017, and is expected to grow at a CAGR of 8.6% to reach $441.1 billion by 2025. The growth of the Asia-Pacific MICE industry is driven by the massive increase in business activities such as client meetings, brand promotions, employee training activities & others, due to rapid rise in the tourism and hospitability sectors and surge in presence of corporate industries. Other significant factors that promote the growth of the market are rise in business travel coupled with change in lifestyle of business travelers to seek leisure trips, rapid urbanization, and increase in disposable incomes. Moreover, surge in government initiatives to promote SMEs and liberalization of market entry to increase FDIs are anticipated to further boost the growth of the industry. However, high cost associated with MICE events and uncertain geopolitical conditions hamper the market growth.

Factors such as investments in infrastructural development and technological advancements are expected to provide lucrative opportunities for the growth of the market. The Asia-Pacific MICE industry is segmented on the basis of event type and country.

Based on event type, the market is classified into meetings, incentives, conventions, and exhibitions. The meeting segment is estimated to account for the major share in the Asia-Pacific MICE industry. This segment is expected to exhibit the highest CAGR during the forecast period due to the growth of the travel & tourism industry, surge in international business travels, and rise in government initiatives for the development of the MICE segment & small and medium enterprises (SME).

By country, it is analyzed across China, India, Singapore, Thailand, Indonesia, Australia, New Zealand, Japan, Malaysia, South Korea, Vietnam, Hong Kong, and rest of Asia-Pacific. China accounted for a significant market share in 2017 and is expected to retain its dominance throughout the forecast period. Singapore is expected to exhibit the highest CAGR during the forecast period. China and Japan collectively accounted for half the share in the Asia-Pacific MICE industry.

The key players operating in the Asia-Pacific MICE industry include Questex, LLC, CWT Meetings & Events, IBTM Events, BCD Meetings and Events, Capital Travel and Events, CiEvents, Conference Care Ltd., The Freeman Company, ATPI Ltd., and Interpublic Group of Companies, Inc.

Key Benefits for MICE Industry Market:

This report provides a quantitative analysis of the current trends, estimations, and dynamics of the Asia-Pacific MICE industry from 2018 to 2025 to identify the prevailing market opportunities.
The key countries in all the major regions are mapped based on their market share.
Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier‐buyer network.
In-depth analysis of the market segmentation assists in determining the prevailing market opportunities.
Major countries in the Asia-Pacific MICE industry are mapped according to their revenue contribution to the industry. Market player positioning segment facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analyses of the key players, market segments, application areas, and growth strategies.

MICE Industry Key Market Segments:

By Event Type

Meetings
Incentives
Conventions
Exhibitions

Country
China
India
Singapore
Thailand
Indonesia
Australia
New Zealand
Japan
Malaysia
South Korea
Vietnam
Hong Kong
Rest of Asia-Pacific


CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Snapshot
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pocket
3.2.2. Top winning strategies
3.3. Porter's five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyer
3.3.3. Thereat of new entrants
3.3.4. Threat of substitute
3.3.5. Intensity of competitive rivalry
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Rapid growth in travel & tourism industry
3.5.1.2. Increase in globalization of businesses
3.5.1.3. Rapid Increase in SMEs
3.5.1.4. Rise in Disposable Income
3.5.2. Restraints
3.5.2.1. High Operational Cost Associated with MICE Events
3.5.2.2. Growth in Geopolitical and Social Uncertainties
3.5.3. Opportunities
3.5.3.1. Technological Advancements
3.5.3.2. Infrastructural Investment
CHAPTER 4: ASIA-PACIFIC MICE INDUSTRY, BY EVENT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Meetings
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis by country
4.3. Incentives
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis by country
4.4. Conventions
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis by country
4.5. Exhibitions
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis by country
CHAPTER 5: ASIA-PACIFIC MICE INDUSTRY, BY COUNTRY
5.1. Overview
5.1.1. Market size and forecast
5.2. China
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast
5.3. India
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast
5.4. Singapore
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast
5.5. Thailand
5.5.1. Key market trends, growth factors, and opportunities
5.5.2. Market size and forecast
5.6. Indonesia
5.6.1. Key market trends, growth factors, and opportunities
5.6.2. Market size and forecast
5.7. Australia
5.7.1. Key market trends, growth factors, and opportunities
5.7.2. Market size and forecast
5.8. New Zealand
5.8.1. Key market trends, growth factors, and opportunities
5.8.2. Market size and forecast
5.9. Japan
5.9.1. Key market trends, growth factors, and opportunities
5.9.2. Market size and forecast
5.10. Malaysia
5.10.1. Key market trends, growth factors, and opportunities
5.10.2. Market size and forecast
5.11. South Korea
5.11.1. Key market trends, growth factors, and opportunities
5.11.2. Market size and forecast
5.12. Vietnam
5.12.1. Key market trends, growth factors, and opportunities
5.12.2. Market size and forecast
5.13. Hong Kong
5.13.1. Key market trends, growth factors, and opportunities
5.13.2. Market size and forecast
5.14. Taiwan
5.14.1. Key market trends, growth factors, and opportunities
5.14.2. Market size and forecast
5.15. Rest of Asia-Pacific
5.15.1. Key market trends, growth factors, and opportunities
5.15.2. Market size and forecast
CHAPTER 6:COMPANY PROFILES
6.1. QUESTEX LLC
6.1.1.Company overview
6.1.2.Business performance
6.1.3.Key strategic moves and developments
6.2. CWT MEETINGS & EVENTS
6.2.1.Company overview
6.2.2.Business performance
6.2.3.Key strategic moves and developments
7.3. IBTM EVENTS
7.3.1.Company overview
7.3.2.Business performance
7.3.3.Key strategic moves and developments
6.4. BCD MEETINGS AND EVENTS
6.4.1.Company overview
6.4.2.Business performance
6.4.3.Key strategic moves and developments
6.5. CIEVENTS
6.5.1.Company overview
6.5.2.Business performance
6.5.3.Key strategic moves and developments
6.6. ATPI LTD.
6.6.1.Company overview
6.6.2.Business performance
6.6.3.Key strategic moves and developments
6.7. CONFERENCE CARE LTD.
6.7.1.Company overview
6.7.2.Business performance
6.7.3.Key strategic moves and developments
6.8. THE FREEMAN COMPANY
6.8.1.Company overview
6.8.2.Business performance
6.8.3.Key strategic moves and developments
6.9. INTERPUBLIC GROUP OF COMPANIES, INC.
6.9.1.Company overview
6.9.2.Business performance
6.9.3.Key strategic moves and developments
6.10. CONFERENCE CARE LTD.
6.10.1.Company overview
6.10.2.Business performance
6.10.3.Key strategic moves and developments
LIST OF TABLES
TABLE 01. COMMERCIALIZED IMMUNOGLOBULIN PRODUCTS
TABLE 02. U.S. FDA INDICATIONS FOR IMMUNOGLOBULIN
TABLE 03. EMA-APPROVED INDICATIONS FOR IMMUNOGLOBULIN
TABLE 04. IGG SUBCLASS
TABLE 05. FREQUENCY (%) OF DECREASED IGG SUBCLASS CONCENTRATION IN ADULTS
TABLE 06. DISEASES ASSOCIATED WITH IGG SUBCLASS DEFICIENCY
TABLE 07. GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 08. GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, BY APPLICATION, 20172025 (KILOGRAM)
TABLE 09. COMMON MEDICATION FOR THE HYPOGAMMAGLOBULINEMIA ASSOCIATED WITH RECURRENT BACTERIAL INFECTIONS
TABLE 10. GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, FOR HYPOGAMMAGLOBULINEMIA, BY REGION, 20172025 ($MILLION)
TABLE 11. GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, FOR HYPOGAMMAGLOBULINEMIA, BY REGION, 20172025 (KILOGRAMS)
TABLE 12. GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, FOR CIDP, BY REGION, 20172025 ($MILLION)
TABLE 13. GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, FOR CIPD, BY REGION, 20172025 (KILOGRAMS)
TABLE 14. GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, FOR PRIMARY IMMUNODEFICIENCY DISEASES BY REGION, 20172025 ($MILLION)
TABLE 15. GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, FOR PRIMARY IMMUNODEFICIENCY DISEASES BY REGION, 20172025 (KILOGRAMS)
TABLE 16. GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, FOR MYASTHENIA GRAVIS (MG), BY REGION, 20172025 ($MILLION)
TABLE 17. GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, FOR MYASTHENIA GRAVIS (MG), BY REGION, 20172025 (KILOGRAMS)
TABLE 18. GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, FOR MULTIFOCAL MOTOR NEUROPATHY, BY REGION, 20172025 ($MILLION)
TABLE 19. GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, FOR MULTIFOCAL MOTOR NEUROPATHY, BY REGION, 20172025 (KILOGRAMS)
TABLE 20. GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP), BY REGION, 20172025 ($MILLION)
TABLE 21. GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP), BY REGION, 20172025 (KILOGRAMS)
TABLE 22. GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, FOR INFLAMMATORY MYOPATHY, BY REGION, 20172025 ($MILLION)
TABLE 23. GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, FOR INFLAMMATORY MYOPATHY, BY REGION, 20172025 (KILOGRAMS)
TABLE 24. GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, FOR SPECIFIC ANTIBODY DEFICIENCY (SAD), BY REGION, 20172025 ($MILLION)
TABLE 25. GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, FOR SPECIFIC ANTIBODY DEFICIENCY (SAD), BY REGION, 20172025 (KILOGRAMS)
TABLE 26. GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, FOR GUILLAIN-BARRE SYNDROME, BY REGION, 20172025 ($MILLION)
TABLE 27. GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, FOR GUILLAIN-BARRE SYNDROME), BY REGION, 20172025 (KILOGRAMS)
TABLE 28. GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, FOR OTHERS, BY REGION, 20172025 ($MILLION)
TABLE 29. GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, FOR OTHERS, BY REGION, 20172025 (KILOGRAMS)
TABLE 30. GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, BY REGION, 20172025 ($MILLION)
TABLE 31. GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, BY REGION, 2017-2025 (KILOGRAMS))
TABLE 32. NORTH AMERICA INTRAVENOUS IMMUNOGLOBULIN MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 33. NORTH AMERICA INTRAVENOUS IMMUNOGLOBULIN MARKET, BY APPLICATION, 20172025 (KILOGRAMS)
TABLE 34. NORTH AMERICA INTRAVENOUS IMMUNOGLOBULIN MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 35. NORTH AMERICA INTRAVENOUS IMMUNOGLOBULIN MARKET, BY COUNTRY, 20172025 (KILOGRAMS)
TABLE 36. EUROPE INTRAVENOUS IMMUNOGLOBULIN MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 37. EUROPE INTRAVENOUS IMMUNOGLOBULIN MARKET, BY APPLICATION, 20172025 (KILOGRAMS)
TABLE 38. EUROPE INTRAVENOUS IMMUNOGLOBULIN MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 39. EUROPE INTRAVENOUS IMMUNOGLOBULIN MARKET, BY COUNTRY, 20172025 (KILOGRAMS)
TABLE 40. ASIA-PACIFIC INTRAVENOUS IMMUNOGLOBULIN MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 41. ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY APPLICATION, 20172025 (KILOGRAMS)
TABLE 42. ASIA-PACIFIC INTRAVENOUS IMMUNOGLOBULIN MARKET, VALUE ($MILLION) AND VOLUME (KILOGRAMS), 2017-2025
TABLE 43. ASIA-PACIFIC INTRAVENOUS IMMUNOGLOBULIN MARKET, BY COUNTRY, 20172025 (KILOGRAMS)
TABLE 44. LAMEA INTRAVENOUS IMMUNOGLOBULIN MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 45. LAMEA IMMUNOGLOBULIN MARKET, BY APPLICATION, 20172025 (KILOGRAMS)
TABLE 46. LAMEA INTRAVENOUS IMMUNOGLOBULIN MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 47. LAMEA INTRAVENOUS IMMUNOGLOBULIN MARKET, BY COUNTRY, 20172025 (KILOGRAMS)
TABLE 48. BAXTER: COMPANY SNAPSHOT
TABLE 49. BAXTER: OPERATING SEGMENTS
TABLE 50. BAXTER: PRODUCT PORTFOLIO
TABLE 51. BAYER: COMPANY SNAPSHOT
TABLE 52. BAYER: OPERATING SEGMENTS
TABLE 53. BAXTER: PRODUCT PORTFOLIO
TABLE 54. BIOTEST: COMPANY SNAPSHOT
TABLE 55. BIOTEST: OPERATING SEGMENTS
TABLE 56. BIOTEST: OPERATING SEGMENT
TABLE 57. CHINA BIOLOGIC COMPANY SNAPSHOT
TABLE 58. CHINA BIOLOGIC PRODUCT PORTFOLIO
TABLE 59. CSL: COMPANY SNAPSHOT
TABLE 60. CSL: PRODUCT SEGMENTS
TABLE 61. CSL: PRODUCT PORTFOLIO
TABLE 62. GRIFOLS: COMPANY SNAPSHOT
TABLE 63. GRIFOLS: OPERATING SEGMENTS
TABLE 64. GRIFOLS: PRODUCT PORTFOLIO
TABLE 65. KEDRION: COMPANY SNAPSHOT
TABLE 66. KEDRION: PRODUCT PORTFOLIO
TABLE 67. LFB: COMPANY SNAPSHOT
TABLE 68. LFB: PRODUCT SEGMENTS
TABLE 69. LFB: PRODUCT PORTFOLIO
TABLE 70. OCTAPHARMA: COMPANY SNAPSHOT
TABLE 71. OCTAPHARMA: PRODUCT SEGMENTS
TABLE 72. OCTAPHARMA: PRODUCT PORTFOLIO
TABLE 73. TAKEDA: COMPANY SNAPSHOT
TABLE 74. TAKEDA: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. KEY MARKET SEGMENTS
FIGURE 02. ASIA-PACIFIC MICE INDUSTRY SNAPSHOT
FIGURE 03. TOP INVESTMENT POCKETS, BY EVENT TYPE
FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05. HIGH BARGAINING POWER OF BUYERS
FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. MODERATE THREAT OF SUBSTITUTION
FIGURE 08. HIGH INTENSITY OF COMPETITIVE RIVALRY
FIGURE 09. MARKET PLAYER POSITIONING, 2017
FIGURE 10. ASIA-PACIFIC MICE INDUSTRY SHARE, BY EVENT TYPE, 2017(%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF ASIA-PACIFIC MEETINGS INDUSTRY ($BILLION), BY COUNTRY, 2017 & 2025 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ASIA-PACIFIC INCENTIVE TRAVEL INDUSTRY ($BILLION), BY COUNTRY, 2017 & 2025 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ASIA-PACIFIC CONVENTIONS INDUSTRY ($BILLION), BY COUNTRY, 2017 & 2025 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ASIA-PACIFIC EXHIBITIONS INDUSTRY ($BILLION), BY COUNTRY, 2017 & 2025 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook